ThermoGenesis (THMO)
(Delayed Data from OTC)
$0.26 USD
+0.03 (14.10%)
Updated Sep 13, 2024 03:48 PM ET
3-Hold of 5 3
A Value A Growth B Momentum A VGM
Income Statements
Fiscal Year end for ThermoGenesis Holdings, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 9 | 10 | 9 | 10 | 13 |
Cost Of Goods | 8 | 8 | 6 | 8 | 7 |
Gross Profit | 2 | 3 | 3 | 1 | 6 |
Selling & Adminstrative & Depr. & Amort Expenses | 11 | 9 | 11 | 10 | 10 |
Income After Depreciation & Amortization | -9 | -6 | -7 | -9 | -5 |
Non-Operating Income | 0 | 0 | 1 | 0 | -1 |
Interest Expense | 10 | 6 | 6 | 8 | 4 |
Pretax Income | -19 | -12 | -12 | -17 | -10 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | -1 | -1 | -1 | 0 | -1 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -19 | -12 | -12 | -17 | -10 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -18 | -11 | -11 | -16 | -10 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 1 | -2 | -3 | -3 | -2 |
Depreciation & Amortization (Cash Flow) | 9 | 4 | 4 | 6 | 3 |
Income After Depreciation & Amortization | -9 | -6 | -7 | -9 | -5 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 2.37 | 0.55 | 0.26 | 0.14 | 0.06 |
Diluted EPS Before Non-Recurring Items | -7.40 | -20.45 | -43.24 | -117.12 | -128.38 |
Diluted Net EPS (GAAP) | -7.59 | -20.45 | -43.24 | -117.12 | -151.35 |
Fiscal Year end for ThermoGenesis Holdings, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 2.74 | 2.41 | 2.19 | 2.27 |
Cost Of Goods | NA | 1.54 | 2.44 | 1.80 | 1.80 |
Gross Profit | NA | 1.20 | -0.04 | 0.40 | 0.47 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 1.76 | 2.21 | 1.96 | 2.20 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -0.56 | -2.25 | -1.56 | -1.73 |
Non-Operating Income | NA | 0.01 | 0.02 | -0.07 | 0.00 |
Interest Expense | NA | 1.45 | 3.34 | 2.12 | 0.67 |
Pretax Income | NA | -2.00 | -7.60 | -3.74 | -2.40 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | -0.15 | -0.59 | -0.13 | -0.14 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -2.00 | -7.60 | -3.74 | -2.40 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -1.86 | -7.01 | -3.62 | -2.26 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 4.03 | 2.37 | 2.50 | 2.48 |
Diluted EPS Before Non-Recurring Items | NA | -0.46 | -2.33 | -1.44 | -0.91 |
Diluted Net EPS (GAAP) | NA | -0.46 | -1.17 | -1.44 | -0.91 |